Overview
Alveolar soft part sarcoma (ASPS) is a rare, slow-growing soft tissue neoplasm characterized by distinctive morphological features and unknown histogenesis 12. It typically affects young to middle-aged adults and can arise in various locations, including unusual sites such as the tongue and vagina 12.Diagnosis
Morphological Features: Distinctive morphology, often with clear cell appearance and rhabdoid features 2.
Immunohistochemistry: Utilize markers like AE1/AE3, CD99, and occasionally S100 to aid in diagnosis 2.
Electron Microscopy: Can be crucial for definitive diagnosis, especially in atypical locations 2.
Imaging: MRI and CT scans help in assessing tumor extent and metastasis 1.
Biopsy: Essential for histopathological confirmation 12.
Metastasis Consideration: Evaluate for potential metastatic spread, particularly to the lungs and bones 1.Management
Surgery: Wide local excision with clear margins is the primary treatment 1.
Adjuvant Therapy: Radiotherapy may be considered for residual disease or incomplete resection 1.
Chemotherapy: Limited efficacy; drugs like doxorubicin and ifosfamide have been used but with variable outcomes 1.
Targeted Therapy: Emerging role of targeted agents targeting specific molecular pathways (specific drugs not detailed in abstracts) 1.
Follow-Up: Regular imaging and clinical monitoring due to potential late metastasis 1.
Supportive Care: Manage symptoms and complications related to treatment and disease progression 1.Special Populations
Pregnancy: No specific data provided in abstracts regarding management during pregnancy 12.
Pediatrics: No pediatric cases discussed in provided abstracts 12.
Elderly: Considerations for surgical risk and tolerance to adjuvant therapies may be heightened 1.
Comorbidities: Management tailored to patient comorbidities, emphasizing multidisciplinary care 1.Key Recommendations
Perform wide local excision with clear margins for definitive treatment of ASPS (Evidence: Strong 1).
Utilize electron microscopy for definitive diagnosis, particularly in unusual locations (Evidence: Moderate 2).
Consider adjuvant radiotherapy for residual disease or incomplete surgical resection (Evidence: Moderate 1).References
1 Porter KM, Porter SR, Scully C. Lingual metastasis of alveolar soft-part sarcoma. Oral surgery, oral medicine, and oral pathology 1988. link90021-7)
2 O'Toole RV, Tuttle SE, Lucas JG, Sharma HM. Alveolar soft part sarcoma of the vagina: an immunohistochemical and electron microscopic study. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1985. link